These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23377394)

  • 1. Are we too cavalier about antiviral prophylaxis?
    Onwudiwe OC; Marmur ES; Cohen JL
    J Drugs Dermatol; 2013 Feb; 12(2):199-205. PubMed ID: 23377394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric acyclovir for neonatal herpes simplex virus infection.
    Vanderpluym C; Tawfik G; Hervas-Malo M; Lacaze-Masmonteil T; Kellner J; Robinson JL
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1278-82. PubMed ID: 21992471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus latency and nucleoside analogues.
    Efstathiou S; Field HJ; Griffiths PD; Kern ER; Sacks SL; Sawtell NM; Stanberry LR
    Antiviral Res; 1999 Apr; 41(3):85-100. PubMed ID: 10320042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area].
    Angel S; Boineau-Géniaux D; Salag P; Trepsat F; Chosidow O; Perrot JL; Will F; Grognard C
    Ann Dermatol Venereol; 1998 Jan; 125(1):74-7. PubMed ID: 9747218
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area.
    Perkins SW; Sklarew EC
    Plast Reconstr Surg; 1996 Sep; 98(3):427-33; discussion 434-5. PubMed ID: 8700976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus hepatitis 4 years after liver transplantation.
    Bissig KD; Zimmermann A; Bernasch D; Furrer H; Dufour JF
    J Gastroenterol; 2003; 38(10):1005-8. PubMed ID: 14614611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
    Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.
    Kabra NS; Thabane L
    Obstet Gynecol; 2004 May; 103(5 Pt 1):1004; author reply 1004-5. PubMed ID: 15121591
    [No Abstract]   [Full Text] [Related]  

  • 11. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
    Alster TS; Nanni CA
    Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is prevention of reactivation of herpes simplex 1 virus necessary in cosmetic surgery and dermatological procedures?].
    Aguilar L; Giménez MJ; Prieto J
    Rev Esp Quimioter; 2005 Jun; 18(2):118-23. PubMed ID: 16130033
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance.
    Epstein JB; Scully C
    Oral Surg Oral Med Oral Pathol; 1991 Jul; 72(1):47-50. PubMed ID: 1653925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children.
    Lim M; Menson E; Tong CY; Lin JP
    J Antimicrob Chemother; 2009 Dec; 64(6):1340-1. PubMed ID: 19828489
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the outcome of facial resurfacing--prevention of herpes simplex virus type 1 reactivation.
    Gilbert S
    J Antimicrob Chemother; 2001 Feb; 47 Suppl T1():29-34. PubMed ID: 11160033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSV shedding.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
    Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
    J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famciclovir as antiviral prophylaxis in laser resurfacing procedures.
    Wall SH; Ramey SJ; Wall F
    Plast Reconstr Surg; 1999 Sep; 104(4):1103-8; discussion 1109. PubMed ID: 10654754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.